Immunicom's Immunotherapy Product Receives U.S. FDA Breakthrough Device Designation for the Treatment of Cancer

SAN DIEGO, May 14, 2018 -- (Healthcare Sales & Marketing Network) -- Immunicom, Inc., a medical technology company developing revolutionary non-pharmaceutical approaches for treating cancer and autoimmune diseases, has received Breakthrough Device designa... Devices, Oncology, FDA Immunicom, Immunopheresis
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news